Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Net Cash Flow (2021 - 2025)

Historic Net Cash Flow for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$5.1 million.

  • MDxHealth's Net Cash Flow fell 11857.63% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.3 million, marking a year-over-year decrease of 22461.02%. This contributed to the annual value of $18.2 million for FY2024, which is 168473.58% up from last year.
  • Latest data reveals that MDxHealth reported Net Cash Flow of -$5.1 million as of Q3 2025, which was down 11857.63% from -$33.2 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Cash Flow ranged from a high of $32.2 million in Q4 2021 and a low of -$33.2 million during Q2 2025
  • Over the past 5 years, MDxHealth's median Net Cash Flow value was -$5.1 million (recorded in 2025), while the average stood at -$62058.8.
  • In the last 5 years, MDxHealth's Net Cash Flow surged by 70181.98% in 2024 and then plummeted by 34743.87% in 2025.
  • MDxHealth's Net Cash Flow (Quarter) stood at $32.2 million in 2021, then crashed by 127.79% to -$8.9 million in 2022, then rose by 29.52% to -$6.3 million in 2023, then surged by 37.31% to -$4.0 million in 2024, then fell by 28.99% to -$5.1 million in 2025.
  • Its Net Cash Flow stands at -$5.1 million for Q3 2025, versus -$33.2 million for Q2 2025 and $16.9 million for Q1 2025.